Skip to Main Content

Paper Details

Preferential tumor localization in relation to <sup>18</sup>F-FDOPA uptake for lower-grade gliomas.
J Neurooncol
2
2021
18F-FDOPA, 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine, FDOPA, LGG, LGGs, Patients, hypermetabolic, isocitrate, isocitrate dehydrogenase, lower-grade gliomas, mutant 1p19q, mutant codeleted, patients, superior frontal gyrus, supplementary motor area, tumor
Author NameAffiliation
Timothy F Cloughesyuniversity of california los angeles Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles
Timothy F CloughesyDavid Geffen School of Medicine, University of California Los Angeles
Timothy F Cloughesyuniversity of california los angeles Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles
Timothy F CloughesyDavid Geffen School of Medicine, University of California Los Angeles
Whitney B PopeDavid Geffen School of Medicine, University of California Los Angeles
Whitney B PopeDavid Geffen School of Medicine, University of California Los Angeles
Noriko SalamonDavid Geffen School of Medicine, University of California Los Angeles
Noriko SalamonDavid Geffen School of Medicine, University of California Los Angeles
Benjamin M Ellingsonuniversity of california los angeles Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles
Benjamin M EllingsonDavid Geffen School of Medicine, University of California Los Angeles
Benjamin M EllingsonUniversity of California Los Angeles
Benjamin M EllingsonDavid Geffen School of Medicine, University of California Los Angeles
Benjamin M Ellingsonuniversity of california los angeles Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles
Benjamin M Ellingsonuniversity of california los angeles Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles
Benjamin M EllingsonDavid Geffen School of Medicine, University of California Los Angeles
Benjamin M EllingsonUniversity of California Los Angeles
Benjamin M EllingsonDavid Geffen School of Medicine, University of California Los Angeles
Benjamin M Ellingsonuniversity of california los angeles Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles
  • 1 - 18

Datasets